Skip to content

Ansa Biotechnologies Expands Successful Early Access Program for Complex DNA Synthesis

  • Published

Ansa Biotechnologies is expanding its early access program for its complex DNA synthesis services. More customers around the world will now be able to take advantage of the company’s innovative enzymatic DNA synthesis technology to accelerate innovation in healthcare, life science research, and other industries powered by synthetic DNA.

View the press release